274 related articles for article (PubMed ID: 19105710)
41. Dendritic cells in the pathogenesis and treatment of human diseases: a Janus Bifrons?
Cools N; Petrizzo A; Smits E; Buonaguro FM; Tornesello ML; Berneman Z; Buonaguro L
Immunotherapy; 2011 Oct; 3(10):1203-22. PubMed ID: 21995572
[TBL] [Abstract][Full Text] [Related]
42. Targeting antigens to dendritic cells in vivo.
Tacken PJ; Torensma R; Figdor CG
Immunobiology; 2006; 211(6-8):599-608. PubMed ID: 16920498
[TBL] [Abstract][Full Text] [Related]
43. Antigen specific tumor immuno-therapy with lentivirus transduced hematopoietic stem cells for transplant.
Whartenby KA
Discov Med; 2003 Dec; 3(19):26-7. PubMed ID: 20705031
[TBL] [Abstract][Full Text] [Related]
44. Immune adjuvants as critical guides directing immunity triggered by therapeutic cancer vaccines.
Schijns V; Tartour E; Michalek J; Stathopoulos A; Dobrovolskienė NT; Strioga MM
Cytotherapy; 2014 Apr; 16(4):427-39. PubMed ID: 24280238
[TBL] [Abstract][Full Text] [Related]
45. Dendritic-tumor fusion cells in cancer immunotherapy.
Takakura K; Kajihara M; Ito Z; Ohkusa T; Gong J; Koido S
Discov Med; 2015 Mar; 19(104):169-74. PubMed ID: 25828520
[TBL] [Abstract][Full Text] [Related]
46. [Optimizing the methods of whole lung cancer RNA-loaded dendritic cells].
Wang K; Wu Y; Zhou Q; Xu C; Lin J; Yang X; Huang S
Zhongguo Fei Ai Za Zhi; 2005 Dec; 8(6):489-94. PubMed ID: 21208534
[TBL] [Abstract][Full Text] [Related]
47. Recent advances in antigen-loaded dendritic cell-based strategies for treatment of minimal residual disease in acute myeloid leukemia.
van den Ancker W; van Luijn MM; Westers TM; Bontkes HJ; Ruben JM; de Gruijl TD; Ossenkoppele GJ; van de Loosdrecht AA
Immunotherapy; 2010 Jan; 2(1):69-83. PubMed ID: 20635890
[TBL] [Abstract][Full Text] [Related]
48. Ex vivo pulsed dendritic cell vaccination against cancer.
Gu YZ; Zhao X; Song XR
Acta Pharmacol Sin; 2020 Jul; 41(7):959-969. PubMed ID: 32366940
[TBL] [Abstract][Full Text] [Related]
49. [Dendritic cell-based immunotherapy for multiple myeloma -- review].
Zhu XJ; He L; Sun XM
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Jun; 17(3):821-5. PubMed ID: 19549416
[TBL] [Abstract][Full Text] [Related]
50. Therapeutic dendritic cell-based cancer vaccines: the state of the art.
Strioga MM; Felzmann T; Powell DJ; Ostapenko V; Dobrovolskiene NT; Matuskova M; Michalek J; Schijns VE
Crit Rev Immunol; 2013; 33(6):489-547. PubMed ID: 24266347
[TBL] [Abstract][Full Text] [Related]
51. Dendritic cells: activation and maturation--applications for cancer immunotherapy.
Sheng KC; Pietersz GA; Wright MD; Apostolopoulos V
Curr Med Chem; 2005; 12(15):1783-800. PubMed ID: 16029147
[TBL] [Abstract][Full Text] [Related]
52. Strategies to improve dendritic cell-based immunotherapy against cancer.
Song SY; Kim HS
Yonsei Med J; 2004 Jun; 45 Suppl():48-52. PubMed ID: 15250050
[TBL] [Abstract][Full Text] [Related]
53. Dendritic cell-based vaccine research against cancer.
Mody N; Dubey S; Sharma R; Agrawal U; Vyas SP
Expert Rev Clin Immunol; 2015 Feb; 11(2):213-32. PubMed ID: 25467734
[TBL] [Abstract][Full Text] [Related]
54. Viral vectors for dendritic cell-based immunotherapy.
Humrich J; Jenne L
Curr Top Microbiol Immunol; 2003; 276():241-59. PubMed ID: 12797451
[TBL] [Abstract][Full Text] [Related]
55. Dendritic Cells and Cancer Immunotherapy: The Adjuvant Effect.
Nava S; Lisini D; Frigerio S; Bersano A
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830221
[TBL] [Abstract][Full Text] [Related]
56. Dendritic cells in cancer immunotherapy: vaccines and combination immunotherapies.
Kalinski P; Muthuswamy R; Urban J
Expert Rev Vaccines; 2013 Mar; 12(3):285-95. PubMed ID: 23496668
[TBL] [Abstract][Full Text] [Related]
57. Engineering dendritic cells to enhance cancer immunotherapy.
Boudreau JE; Bonehill A; Thielemans K; Wan Y
Mol Ther; 2011 May; 19(5):841-53. PubMed ID: 21468005
[TBL] [Abstract][Full Text] [Related]
58. Harnessing the Antiviral-Type Responses Induced by Immunostimulatory siRNAs for Cancer Immunotherapy.
Iversen PO; Sioud M
Methods Mol Biol; 2020; 2115():281-287. PubMed ID: 32006407
[TBL] [Abstract][Full Text] [Related]
59. Hematologic neoplasms: Dendritic cells vaccines in motion.
Galati D; Zanotta S
Clin Immunol; 2017 Oct; 183():181-190. PubMed ID: 28870867
[TBL] [Abstract][Full Text] [Related]
60. RNA-loaded dendritic cells: more than a
Joshi A; Tandel N; Tyagi P; Dalai SK; Bisen PS; Tyagi RK
Immunotherapy; 2019 Sep; 11(13):1129-1147. PubMed ID: 31390917
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
